Ms. Tong’s experience includes advising:
- FountainVest Partners in its $900 million acquisition of Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
- PTK Acquisition Corp. (NYSE: PTK) in their $1.1 billion business combination with Valens Semiconductor
- Tiancheng International Investment in its proposed €1.1 billion sale of Tiancheng Pharmaceutical Holding AG to Grifols
- Hillhouse Investment in various investments in biotech companies and joint ventures with sports companies
- DST Global in its Asian investments including Airwallex and Kuaishou